Workflow
Hicin Pharmaceutical(300584)
icon
Search documents
海辰药业(300584) - 第四届董事会第二十二次会议决议公告
2025-06-26 12:45
证券代码:300584 证券简称:海辰药业 公告编号:2025-029 南京海辰药业股份有限公司 第四届董事会第二十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 公司第四届董事会即将任期届满,为了顺利完成第五届董事会的换届选举, 根据《中华人民共和国公司法》(2023 年修订)、《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》(2025 年修订)等有关法律、 行政法规、部门规章、规范性文件及《公司章程》的有关规定,会议按照法律程 一、董事会会议召开情况 1、本次董事会由董事长曹于平先生召集,会议通知于 2025 年 6 月 23 日通 过电话、电子邮件、专人送达等形式送达至各位董事,董事会会议通知中包括会 议的相关材料,同时列明了会议的召开时间、地点、内容和方式。 2、本次董事会于 2025 年 6 月 26 日在公司会议中心三楼会议室召开,本次 会议采取现场结合通讯表决方式召开。 3、本次董事会应出席 9 人,实际出席会议人数为 9 人。其中毛凌霄、李翔 以通讯表决方式参会。 4、本次董事会由董事长曹于平先生主 ...
820只股短线走稳 站上五日均线
Core Points - The Shanghai Composite Index closed at 3365.07 points, below the five-day moving average, with a change of 0.15% [1] - The total trading volume of A-shares reached 683.87 billion yuan [1] - A total of 820 A-shares have prices that surpassed the five-day moving average [1] Individual Stock Performance - SanDe Technology (300515) had a price increase of 19.98% with a deviation rate of 13.78% from the five-day moving average [2] - HaiXin Energy Technology (300072) saw a price increase of 20.06% with a deviation rate of 12.77% [2] - QiLin Information Security (688152) experienced a price increase of 13.18% with a deviation rate of 9.66% [2] - Other notable stocks include TengYuan Cobalt (301219) with a 14.39% increase and a 9.34% deviation rate, and Jiangsu BoYun (301003) with a 14.60% increase and a 9.11% deviation rate [2]
128只A股筹码大换手(6月12日)
Market Overview - As of June 12, the Shanghai Composite Index closed at 3402.66 points, with a slight increase of 0.34 points, representing a change of 0.01% [1] - The Shenzhen Component Index closed at 10234.33 points, down by 11.69 points, a decrease of 0.11% [1] - The ChiNext Index closed at 2067.15 points, up by 5.29 points, reflecting an increase of 0.26% [1] Trading Activity - A total of 128 A-shares had a turnover rate exceeding 20% on the same day, indicating significant trading activity [1] - Notably, C Haiyang and Zhongke Magnetic had turnover rates exceeding 50%, suggesting a high level of liquidity and interest in these stocks [1] Top Performing Stocks - C Haiyang (603382) had a closing price of 55.97 yuan with a turnover rate of 85.43% and a remarkable increase of 386.70% [1] - Zhongke Magnetic (301141) closed at 68.13 yuan, with a turnover rate of 67.96% and a gain of 3.20% [1] - Yingsite (301622) closed at 97.32 yuan, achieving a turnover rate of 60.53% and a rise of 20.00% [1] - Jiangnan New Materials (603124) closed at 48.20 yuan, with a turnover rate of 57.58% and an increase of 4.83% [1] - Xiongdi Technology (300546) closed at 34.41 yuan, with a turnover rate of 56.64% and a gain of 7.20% [1] Additional Notable Stocks - Kangliyuan (301287) closed at 50.52 yuan, with a turnover rate of 48.58% and a slight decrease of 0.26% [1] - Qingmu Technology (301110) closed at 72.42 yuan, achieving a turnover rate of 46.33% and a rise of 20.00% [1] - Baixinglong (833075) closed at 46.99 yuan, with a turnover rate of 44.54% and an increase of 29.99% [1] - Hengbao Co., Ltd. (002104) closed at 11.82 yuan, with a turnover rate of 44.51% and a gain of 2.34% [1] - Guokang Biochemical (300804) closed at 61.10 yuan, with a turnover rate of 42.76% and a slight increase of 1.08% [1]
A股化学制药板块震荡回调,海辰药业、永安药业均跌超9%,一品红、哈三联、通化金马、翰宇药业、河化股份等均跌5%。
news flash· 2025-06-11 03:14
Group 1 - The A-share chemical pharmaceutical sector is experiencing a volatile correction, with companies such as Haichen Pharmaceutical and Yong'an Pharmaceutical both declining over 9% [1] - Other companies including Yipinhong, Hasanlian, Tonghua Jinma, Hanyu Pharmaceutical, and Hehua Co. have also seen declines of around 5% [1]
海辰药业(300584) - 南京海辰药业股份有限公司关于第一期员工持股计划股份出售完毕暨终止的公告
2025-06-10 10:56
证券代码:300584 证券简称:海辰药业 公告编号:2025-028 南京海辰药业股份有限公司 关于第一期员工持股计划股份出售完毕暨终止的公告 二、本期员工持股计划所持股票的出售情况及后续安排 截至本公告披露日,公司本期员工持股计划所持有的 3,848,130 股股票, 占公司总股本的 3.21%,已通过二级市场集中竞价交易方式全部出售完毕。本 期员工持股计划持股期间与披露的《南京海辰药业股份有限公司第一期员工持 股计划(草案)》的存续期一致。公司实施第一期员工持股计划期间,严格遵 守市场交易规则及中国证监会、深圳证券交易所关于股票买卖的规定,不存在 利用内幕信息进行交易的情形。根据员工持股计划的有关规定,本期员工持股 计划已实施完毕并终止,后续将进行相关资产的清算,并按持有人持有的份额 进行分配。 一、本期员工持股计划的基本情况 2018 年 2 月 6 日,公司召开 2018 年第一次临时股东大会审议通过了《关 于<南京海辰药业股份有限公司第一期员工持股计划(草案)>及摘要的议案》 《关于提请股东大会授权董事会办理公司第一期员工持股计划相关事宜的议 案》。2018 年 3 月 15 日,公司召开第二届董 ...
A股创新药板块持续活跃,众生药业、昂利康涨停,联化科技涨超9%,睿智医药、海辰药业、翰宇药业等高开。
news flash· 2025-06-10 01:34
A股创新药板块持续活跃,众生药业、昂利康涨停,联化科技涨超9%,睿智医药、海辰药业、翰宇药 业等高开。 订阅A股涨停捉妖队 +订阅 订阅A股市场资讯 +订阅 ...
创新药概念爆发 稀土板块拉升
Mei Ri Shang Bao· 2025-06-09 22:16
Market Performance - A-shares showed strong momentum with major indices rising, Shanghai Composite Index surpassed 3400 points, and ChiNext Index increased over 1% [1] - Hong Kong stocks also performed well, with the Hang Seng Index rising over 1% and returning above 24000 points, while the Hang Seng Tech Index surged nearly 3% [1] - Total market turnover reached approximately 1.31 trillion yuan, an increase of 135.5 billion yuan from the previous trading day [1] Innovative Drug Sector - The innovative drug concept stocks experienced significant gains, with the innovative drug index rising over 4% [2] - Notable stocks included Hai Chen Pharmaceutical, Rui Zhi Pharmaceutical, and others, with nearly 15 related stocks hitting the daily limit or rising over 10% [2] - Since mid-May, innovative drug stocks have shown strong performance, with some stocks like Lianhua Technology increasing nearly 115% in the last nine trading days [2] Industry Developments - The 2025 American Society of Clinical Oncology (ASCO) annual meeting highlighted the competitiveness of Chinese pharmaceutical companies in new drug development [3] - Financial policies introduced since May 7 aim to stabilize market expectations, with a focus on supporting leading pharmaceutical companies with strong dividends [3] Rare Earth Sector - The rare earth sector became active, with the rare earth permanent magnet concept index rising 3.45% [4] - The demand for medium and heavy rare earths is increasing due to the development of industries like robotics and electric vehicles [4] - Supply tightening and policy changes have led to a recovery in rare earth prices, with expectations for continued moderate price increases [5] Elderly Care Robotics - The elderly care robotics sector showed strong performance, with the humanoid robot concept index rising 0.76% [7] - The Ministry of Industry and Information Technology and the Ministry of Civil Affairs announced a pilot program for intelligent elderly care service robots from 2025 to 2027 [7] - The report emphasized the investment value of the robotics sector, highlighting various types of intelligent elderly care robots that cater to different needs [8]
6月9日重要资讯一览
Group 1 - New stock offering for Huazhi Jie with an issuance price of 19.88 yuan per share and a subscription limit of 0.80 million shares [2] - The State Statistics Bureau reported a decrease in the Consumer Price Index (CPI) by 0.2% month-on-month and 0.1% year-on-year for May, while the Producer Price Index (PPI) fell by 0.4% month-on-month and 3.3% year-on-year, with the year-on-year decline widening by 0.6 percentage points [4] - The General Administration of Customs announced that China's total goods trade value for the first five months reached 17.94 trillion yuan, a year-on-year increase of 2.5%, with exports at 10.67 trillion yuan (up 7.2%) and imports at 7.27 trillion yuan (down 3.8%) [4] Group 2 - Shenzhen Stock Exchange announced adjustments to the Hong Kong Stock Connect eligible securities list, with new additions including Bruker, Gu Ming, and Mixue Group, effective from June 9, 2025 [5] - Beijing's Economic and Information Technology Bureau and other departments released a plan for high-quality development of the fashion industry from 2025 to 2027, focusing on immersive experiences and new retail models to enhance product consumption [5] - The Suzhou Artificial Intelligence Industry Association plans to collect innovative products and solutions to enhance the performance of the Suzhou football team in the 2025 Jiangsu Province Urban Football League [5] Group 3 - Co-creation Turf reported that the impact of domestic football sports events on the company's operating performance is minimal [7] - Filinger announced a suspension of trading starting June 10 for stock price fluctuation investigation [7] - Yiyuan Lithium Energy is planning to issue H-shares and list on the Hong Kong Stock Exchange [7]
A股公告精选 | 共创草坪(605099.SH)、昂利康(002940.SZ)等连板股提示交易风险
智通财经网· 2025-06-09 12:24
Group 1 - Company Gongchuang Turf (605099.SH) stated that the impact of domestic football events on its operations and performance is minimal, as its main business of artificial turf has a low revenue contribution from domestic sports grass [1] - Company Anglikang (002940.SZ) confirmed that its innovative drug project ALK-N001 is still in Phase I clinical trials, indicating a long R&D cycle and significant investment [2] - Company Yiwei Lithium Energy (300014.SZ) plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance capital strength and international brand image [3] Group 2 - Company Chaohongji (002345.SZ) also intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange to advance its global strategy and improve competitiveness [4] - Company Dexin Technology (603032.SH) clarified that its subsidiary's sales revenue from products used in solid-state battery production is less than 1% of total revenue, emphasizing its focus on quality service [5] - Company Changshan Pharmaceutical (300255.SZ) announced that its application for the marketing authorization of Aibennapeptide injection for type 2 diabetes has been accepted, but the approval timeline remains uncertain [6] Group 3 - Company Baili Electric (600468.SH) reported that its revenue from nuclear fusion-related business is currently minimal, accounting for less than 1% of total revenue [7] - Company Chutianlong (003040.SZ) is exploring digital currency projects but faces risks related to new technology development and commercial application [8] - Company Dongxing Medical (301290.SZ) signed contracts with Shanghai Jiao Tong University for synthetic biology technology development, totaling 6 million yuan, enhancing its R&D capabilities [9] Group 4 - Company Maixinlin (688685.SH) announced that its subsidiary signed contracts for computing power services worth 1.184 billion yuan, expected to positively impact future performance [10] - Company Haichen Pharmaceutical (300584.SZ) reported that its solid-state battery-related business has not yet generated revenue, which does not significantly affect overall performance [11] - Company Filinger (603226.SH) is undergoing stock trading suspension for investigation due to significant price deviations from fundamentals [12] Group 5 - Company Zhongdian Port (001287.SZ) disclosed that the National Integrated Circuit Fund reduced its stake by 1%, now holding 8.97% of the company [13] - Company Huasheng Co., Ltd. (600156.SH) is planning to acquire 100% of Yixin Technology, leading to a stock suspension for up to 10 trading days [14] - Company Jianghuai Automobile reported a 3.52% year-on-year decline in May sales, with new energy vehicle sales down 57.81% [15] - Company Aonong Biological reported a 9.44% year-on-year increase in May pig sales, with a total of 156,200 pigs sold [16]
海辰药业龙虎榜数据(6月9日)
海辰药业今日涨停,全天换手率32.21%,成交额10.31亿元,振幅15.40%。龙虎榜数据显示,机构净买 入1845.58万元,营业部席位合计净卖出9001.30万元。 深交所公开信息显示,当日该股因日收盘价涨幅达20.00%上榜,机构专用席位净买入1845.58万元。 海辰药业6月9日交易公开信息 | 买/ | 会员营业部名称 | 买入金额(万 | 卖出金额(万 | | --- | --- | --- | --- | | 卖 | | 元) | 元) | | 买一 | 机构专用 | 3144.52 | 4130.70 | | 买二 | 华林证券股份有限公司北京分公司 | 3037.58 | 14.93 | | 买三 | 机构专用 | 2015.65 | 637.41 | | 买四 | 东海证券股份有限公司福州长乐北路证券营业部 | 1501.49 | 0.00 | | 买五 | 机构专用 | 1453.52 | 0.00 | | 卖一 | 国泰海通证券股份有限公司上海松江区中山东路证券营 业部 | 4.76 | 5373.69 | | 卖二 | 机构专用 | 3144.52 | 4130.70 | | 卖三 ...